Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
Completed · Phase 2
Conditions studied: Dry Eye Disease
In brief
Phase 2 study to assess the efficacy of topically administered eyedrops of INV-102 during 4-week repeat dosing in subjects with moderate to severe dry eye disease.
Key facts
- Study ID
- NCT06370039
- Run by
- Invirsa, Inc.
- People needed
- 109
- Starts
- 2024-03-27
- Expected to finish
- 2024-07-03
- Last updated by the study team
- 2025-07-02
Who can join
Age: 18 and older, up to 74. Sex: any. Healthy volunteers: not accepted.
Where it is running
- iuvo BioScience — Rush, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.